Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000374282

Medchemexpress LLC Repaglinide-d5 | 1217709-85-7 | C27H31D5N2O4 | 25 MG
SDP

Catalog No. 5000374282
Encompass_Preferred

Repaglinide-d5 is a deuterium-labeled variant of Repaglinide. Repaglinide acts as an insulin secretagogue, primarily used in the treatment of type-2 diabetes mellitus. It functions by enhancing the early phase of insulin secretion and increasing the overall amount of insulin released, which helps to reduce postprandial glucose levels.

  • Used as a tracer.
  • Serves as an internal standard for quantitative analysis using techniques such as NMR, GC-MS, or LC-MS.

Catalog No. 50-003-74282 Supplier Medchemexpress LLC Supplier No. 25MGHY15209S
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Repaglinide-d5 is a deuterium-labeled variant of Repaglinide. Repaglinide acts as an insulin secretagogue, primarily used in the treatment of type-2 diabetes mellitus. It functions by enhancing the early phase of insulin secretion and increasing the overall amount of insulin released, which helps to reduce postprandial glucose levels.

  • Used as a tracer.
  • Serves as an internal standard for quantitative analysis using techniques such as NMR, GC-MS, or LC-MS.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.